Form D · Other Health Care
Resolve Therapeutics LLC
Seattle, WA · CIK 0001520680
Offering snapshot reported Jan 17, 2013 · SEC filing
- Reported sold
- $5.83M Offering amount: $5.83M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 2, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 17, 2013 | Initial | $5,833,343 | No comparison | 6 | SEC filing |
| Apr 25, 2012 | Initial | $1,083,334 | No comparison | 4 | SEC filing |
| May 13, 2011 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-190410
Source: Form D, filed Jan 17, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Kiener | Executive |
| James Posada | Executive, Promoter |
| Somu Subramaniam | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
454 North 34th Street
Seattle, WA, 98103
Seattle, WA, 98103